These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 18928580)

  • 21. Clinical implications of the quantitative detection of ID4 gene methylation in myelodysplastic syndrome.
    Kang H; Wang X; Gao L; Cen J; Li M; Wang W; Wang N; Li Y; Wang L; Yu L
    Eur J Med Res; 2015 Feb; 20(1):16. PubMed ID: 25889027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis.
    Martini M; Cenci T; D'Alessandris GQ; Cesarini V; Cocomazzi A; Ricci-Vitiani L; De Maria R; Pallini R; Larocca LM
    Cancer; 2013 Mar; 119(5):1004-12. PubMed ID: 23132729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of heteroplasmic mutations in the mitochondrial genome and the ID4 gene promoter methylation region in the pathogenesis of chronic aplastic anemia in patients suffering from Kidney yin deficiency.
    Cui X; Wang JY; Liu K; Cui SY; Zhang J; Luo YQ; Wang X
    Chin J Integr Med; 2016 Jun; 22(6):412-9. PubMed ID: 25920536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CpG island methylator phenotype and its relationship with prognosis in adult acute leukemia patients.
    Fu HY; Wu DS; Zhou HR; Shen JZ
    Hematology; 2014 Sep; 19(6):329-37. PubMed ID: 24164743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative Detection of ID4 Gene Aberrant Methylation in the Differentiation of Myelodysplastic Syndrome from Aplastic Anemia.
    Li MY; Xu YY; Kang HY; Wang XR; Gao L; Cen J; Wang W; Wang N; Li YH; Wang LL; Yu L
    Chin Med J (Engl); 2015 Aug; 128(15):2019-25. PubMed ID: 26228212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent DNA methylation but not mutation of the ID4 gene in malignant lymphoma.
    Hagiwara K; Nagai H; Li Y; Ohashi H; Hotta T; Saito H
    J Clin Exp Hematop; 2007 Apr; 47(1):15-8. PubMed ID: 17510533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [LRP15 gene promoter region methylation and its expression in acute leukemia].
    Zhao Y; Dou LP; Wang QS; Lu XC; Lou FD; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):39-41. PubMed ID: 17490517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
    Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
    Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical Significance of ID4 Gene Mehtylation in Demethylation-Treated MDS Cell Line and 2 MDS Patients].
    Kang HY; Wang XR; Gao L; Wang W; Li MY; Wang LL; Wang CB; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Apr; 23(2):455-9. PubMed ID: 25948204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged persistence of PCR-detectable minimal residual disease after diagnosis or first relapse predicts poor outcome in childhood B-precursor acute lymphoblastic leukemia.
    Steenbergen EJ; Verhagen OJ; van Leeuwen EF; van den Berg H; Behrendt H; Slater RM; von dem Borne AE; van der Schoot CE
    Leukemia; 1995 Oct; 9(10):1726-34. PubMed ID: 7564517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis.
    Umetani N; Takeuchi H; Fujimoto A; Shinozaki M; Bilchik AJ; Hoon DS
    Clin Cancer Res; 2004 Nov; 10(22):7475-83. PubMed ID: 15569977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Methylation of CpG island in promoter region of RUNX2 gene and its expression in HOX11(+) acute T lymphoblastic leukemia].
    Jia JS; Salvatore S
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):273-8. PubMed ID: 23628015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cdc42 is highly expressed in colorectal adenocarcinoma and downregulates ID4 through an epigenetic mechanism.
    Gómez Del Pulgar T; Valdés-Mora F; Bandrés E; Pérez-Palacios R; Espina C; Cejas P; García-Cabezas MA; Nistal M; Casado E; González-Barón M; García-Foncillas J; Lacal JC
    Int J Oncol; 2008 Jul; 33(1):185-93. PubMed ID: 18575765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cloning of ID4 gene expression regulation promoter and subcloning of recombinant ID4 promoter luciferase reporter].
    Li W; Huang Y; Yang B; Chi XH; Liu LH; Zhang F; Yan JW; Lu XC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):421-6. PubMed ID: 20416180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypomethylation of DNA-binding inhibitor 4 serves as a potential biomarker in distinguishing acquired tamoxifen-refractory breast cancer.
    Zhang Y; Zhang B; Fang J; Cao X
    Int J Clin Exp Pathol; 2015; 8(8):9500-5. PubMed ID: 26464711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of TFPI-2 gene and its promoter methylation in acute myeloid leukemia].
    Shao LL; Fan J; Wang R; Feng LL; Zhen CQ; Sui XH; Li Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):920-6. PubMed ID: 25130804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Significance of DNA methylation status of runx3 gene promoter region in acute leukemia].
    Lin DJ; Fan RF; Liu XF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):263-6. PubMed ID: 18426645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant methylation in promoter-associated CpG islands of multiple genes in relapsed childhood acute lymphoblastic leukemia.
    Matsushita C; Yang Y; Takeuchi S; Matsushita M; Van Dongen JJ; Szczepanski T; Bartram CR; Seo H; Koeffler HP; Taguchi H
    Oncol Rep; 2004 Jul; 12(1):97-9. PubMed ID: 15201966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia.
    Agrawal S; Unterberg M; Koschmieder S; zur Stadt U; Brunnberg U; Verbeek W; Büchner T; Berdel WE; Serve H; Müller-Tidow C
    Cancer Res; 2007 Feb; 67(3):1370-7. PubMed ID: 17283175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ID4 is frequently downregulated and partially hypermethylated in prostate cancer.
    Vinarskaja A; Goering W; Ingenwerth M; Schulz WA
    World J Urol; 2012 Jun; 30(3):319-25. PubMed ID: 21882048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.